Wire
Home
Browse Releases
Publishers
Subscriber
Free Tools
Submit a Release
Login
Register
Wire
Articles
Publishers
Subscribers
Tools
Submit Release
Wire
Browse the Wire
"fda" โ Press Releases
8,255 releases found
Search
Active filters:
๐ fda
ร
Clear all ร
๐ Health
๐ฃ PR News
Lunit's AI Software for Breast Cancer Detection, Lunit INSIGHT MMG, Wins FDA Clearance
Expertini PR News ยท 1640 days ago
Read Release โ
๐ Pickups
๐ Health
๐ฃ PR News
Isofol Medical AB (publ) will not reach 300 PFS events in the AGENT study with current censoring rules based on FDA decision
Expertini PR News ยท 1642 days ago
Read Release โ
๐ Pickups
๐ Technology
๐ฃ PR News
ๆฐๆ็งๆๅฎๆดEDAๆต็จ็ๅ ่ทๅพไธๆ4LPPๅทฅ่บ่ฎค่ฏ
Expertini PR News ยท 1644 days ago
Read Release โ
๐ Pickups
๐ Business
๐ฃ PR News
Moleculin Receives FDA Allowance to Begin a Phase 1 Study of WP1122 for the Treatment of Glioblastoma Multiforme
Expertini PR News ยท 1644 days ago
Read Release โ
๐ Pickups
๐ Business
๐ฃ PR News
U.S. FDA Grants Bionomics Fast Track Designation to BNC210 for the Acute Treatment of Social Anxiety Disorder and Other Anxiety Related Disorders
Expertini PR News ยท 1645 days ago
Read Release โ
๐ Pickups
๐ Business
๐ฃ PR News
The Great EDA Migration: 85% of businesses striving for Event-Driven Architecture
Expertini PR News ยท 1645 days ago
Read Release โ
๐ Pickups
๐ Health
๐ฃ PR News
Evofem Biosciences Announces Successful Type C Meeting with FDA for STI Prevention Product Candidate
Expertini PR News ยท 1645 days ago
Read Release โ
๐ Pickups
๐ Business
๐ฃ PR News
RegeneRx Joint Venture Requests Pre-BLA Meeting with FDA For RGN-259 for Dry Eye Syndrome
Expertini PR News ยท 1646 days ago
Read Release โ
๐ Pickups
๐ Health
๐ฃ PR News
Viracta Therapeutics Announces Orphan Drug Designation Granted by FDA for its All-Oral Combination of Nanatinostat and Valganciclovir (Nana-val) for the Treatment of Epstein Barr Virus-Positive Diffuse Large B-cell Lymphoma
Expertini PR News ยท 1646 days ago
Read Release โ
๐ Pickups
๐ Business
๐ฃ PR News
Takedaโs LIVTENCITYTM (maribavir) Approved by U.S. FDA as the First and Only Treatment for People Ages 12 and Older with Post-Transplant Cytomegalovirus (CMV), Refractory (With or Without Genotypic Resistance) to Conventional Antiviral Therapies. OSAKA, Japan & CAMBRIDGE, Mass., TAKEDA-PHARMACEUTICAL
Expertini PR News ยท 1652 days ago
Read Release โ
๐ Pickups
๐ Business
๐ฃ PR News
Fannie Mae Priced $640 Million Social Multifamily DUS REMIC (FNA 2021-M2S) Under Its GeMS Program
Expertini PR News ยท 1653 days ago
Read Release โ
๐ Pickups
๐ Science
๐ฃ PR News
Pentwater Issues Public Letter to George Burns Regarding Ongoing Breaches of Fiduciary Duty. NAPLES, Fla., FL-PENTWATER
Expertini PR News ยท 1653 days ago
Read Release โ
๐ Pickups
๐ Business
๐ฃ PR News
Siemens Energy to Help U.S. Government Reduce Emissions on New National Oceanographic and Atmospheric Administration (NOAA) Ships. ORLANDO, Fla., FL-SIEMENS-ENERGY
Expertini PR News ยท 1653 days ago
Read Release โ
๐ Pickups
๐ Health
๐ฃ PR News
SyneuRx Announces Oral COVID-19 Twindemic Antiviral Drug Candidate Pentarlandir Has Entered Final Portion of FDA Phase II Testing
Expertini PR News ยท 1656 days ago
Read Release โ
๐ Pickups
๐ Health
๐ฃ PR News
La sociรฉtรฉ SyneuRx annonce que le Pentarlandir, candidat-mรฉdicament et antiviral oral pour lutter contre le COVID-19 Twindemic, est entrรฉ dans la derniรจre partie des essais de phase II de la FDA (Agence fรฉdรฉrale amรฉricaine des produits alimentaires et mรฉdicamenteux)
Expertini PR News ยท 1656 days ago
Read Release โ
๐ Pickups
๐ Health
๐ฃ PR News
SyneuRxโข gibt bekannt, dass der orale antivirale COVID-19-Kandidat Pentarlandirยฎ den letzten Teil der FDA-Phase-II-Tests erreicht hat
Expertini PR News ยท 1656 days ago
Read Release โ
๐ Pickups
๐ Health
๐ฃ PR News
Gracell Biotechnologies Granted FDA Orphan Drug Designation for FasTCAR-enabled BCMA/CD19 Dual-targeting CAR-T Cell Therapy Candidate GC012F for the Treatment of Multiple Myeloma
Expertini PR News ยท 1657 days ago
Read Release โ
๐ Pickups
๐ Business
๐ฃ PR News
Pentwater Issues Public Letter on Corporate Governance to Rio Tinto Director Ben Wyatt. NAPLES, Fla., FL-PENTWATER-CAPITAL
Expertini PR News ยท 1657 days ago
Read Release โ
๐ Pickups
๐ Health
๐ฃ PR News
Heron Therapeutics Announces Submission of HTX-019 NDA for the Prevention of Postoperative Nausea and Vomiting to FDA
Expertini PR News ยท 1657 days ago
Read Release โ
๐ Pickups
๐ Business
๐ฃ PR News
็พๅฝFDAๆ ธๅBESREMiยฎ (Ropeginterferon ฮฑ-2b). ็ปดไน็บณ, AOP-ORPHAN
Expertini PR News ยท 1657 days ago
Read Release โ
๐ Pickups
โน
1
โฆ
410
411
412
413
โบ
๐ฃ
Distribute Your Release
Reach 1.25M+ monthly readers. Free to start, $15 for full distribution.
Submit a Release
By Industry
๐ฏ
Recruitment & Hiring
0
๐ฅ
Human Resources
0
๐ค
Artificial Intelligence
0
โ๏ธ
HR Technology
0
๐ข
Workplace & Culture
0
๐
Diversity & Inclusion
0
๐ฎ
Future of Work
0
๐ฐ
Compensation & Benefits
0
๐
Learning & Development
0
โญ
Talent Management
0
๐
Labour Market & Economics
0
๐
Executive Appointments
0
๐ค
Mergers & Acquisitions
0
๐
Product Launches
0
๐
Research & Reports
0
๐ค
Events & Conferences
0
๐ฅ
Awards & Recognition
0
๐
Partnerships & Integrations
0
๐ฐ
Company News
0
๐
Other
0
By Release Type
๐ฃ
Press Release
181
๐ข
Announcement
0
๐
Product Launch
0
๐
Report
0
๐ค
Event
0
๐
Case Study
0
๐
White Paper
0
๐๏ธ
Interview
0
๐ฌ
Opinion
0
๐
Article Alerts
Get notified when new releases match your keywords or category.
Set Up Alerts